Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24599287)

1.

Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.

Walentowicz P, Krintus M, Sadlecki P, Grabiec M, Mankowska-Cyl A, Sokup A, Walentowicz-Sadlecka M.

PLoS One. 2014 Mar 5;9(3):e90575. doi: 10.1371/journal.pone.0090575. eCollection 2014.

2.
3.

Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.

Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.

Acta Obstet Gynecol Scand. 2008;87(11):1136-42. doi: 10.1080/00016340802478158.

PMID:
18951217
4.

Inhibin A, B and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumors.

Ala-Fossi SL, Mäenpää J, Bläuer M, Tuohimaa P, Punnonen R.

Eur J Endocrinol. 2000 Apr;142(4):334-9.

5.

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer.

Sallinen H, Heikura T, Koponen J, Kosma VM, Heinonen S, Ylä-Herttuala S, Anttila M.

BMC Cancer. 2014 Sep 23;14:696. doi: 10.1186/1471-2407-14-696.

6.

Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma.

Menon U, Riley SC, Thomas J, Bose C, Dawnay A, Evans LW, Groome NP, Jacobs IJ.

BJOG. 2000 Sep;107(9):1069-74.

PMID:
11002947
7.

25(OH)D3 in patients with ovarian cancer and its correlation with survival.

Walentowicz-Sadlecka M, Grabiec M, Sadlecki P, Gotowska M, Walentowicz P, Krintus M, Mankowska-Cyl A, Sypniewska G.

Clin Biochem. 2012 Dec;45(18):1568-72. doi: 10.1016/j.clinbiochem.2012.07.110. Epub 2012 Aug 4.

PMID:
22884489
8.

Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumors.

Blaakaer J, Micic S, Morris ID, Hørding U, Bennett P, Toftager-Larsen K, Djursing H, Bock JE.

Eur J Obstet Gynecol Reprod Biol. 1993 Dec 15;52(2):105-10.

PMID:
8157138
9.

Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?

Chan JK, Loizzi V, Lin YG, Osann K, Brewster WR, DiSaia PJ.

Obstet Gynecol. 2003 Jul;102(1):156-61.

PMID:
12850623
10.

Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.

Robertson DM, Stephenson T, Pruysers E, McCloud P, Tsigos A, Groome N, Mamers P, Burger HG.

J Clin Endocrinol Metab. 2002 Feb;87(2):816-24.

PMID:
11836327
11.

Total inhibin is a potential serum marker for epithelial ovarian cancer.

Tsigkou A, Marrelli D, Reis FM, Luisi S, Silva-Filho AL, Roviello F, Triginelli SA, Petraglia F.

J Clin Endocrinol Metab. 2007 Jul;92(7):2526-31. Epub 2007 May 1.

PMID:
17473066
12.

Preoperative serum inhibin levels in patients with ovarian tumors.

El-Shalakany A, Abou-Talib Y, Shalaby HS, Sallam M.

J Obstet Gynaecol Res. 2004 Apr;30(2):155-61.

PMID:
15009621
13.

Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients.

Tas F, Karabulut S, Serilmez M, Ciftci R, Duranyildiz D.

Tumour Biol. 2014 Apr;35(4):3327-31. doi: 10.1007/s13277-013-1438-z. Epub 2013 Nov 24.

PMID:
24272203
14.

Early stage epithelial ovarian cancers: a study of morphologic prognostic factors.

Terzi A, Aktaş IY, Dolgun A, Ayhan A, Küçükali T, Usubütün A.

Pathol Res Pract. 2013 Jun;209(6):359-64. doi: 10.1016/j.prp.2013.03.009. Epub 2013 Mar 30.

PMID:
23643734
15.

Serum TRAIL levels in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. A pilot study.

Gasowska-Bodnar A, Bodnar L, Synowiec A, Jerzak M, Wcislo G, Smoter M, Szczylik C, Baranowski W.

Eur J Gynaecol Oncol. 2011;32(6):642-6.

PMID:
22335026
16.

Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer.

Plante M, Rubin SC, Wong GY, Federici MG, Finstad CL, Gastl GA.

Cancer. 1994 Apr 1;73(7):1882-8.

PMID:
8137215
17.

Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer.

Prat A, Parera M, Peralta S, Perez-Benavente MA, Garcia A, Gil-Moreno A, Martinez-Palones JM, Roxana I, Baselga J, Del Campo JM.

Ann Oncol. 2008 Feb;19(2):327-31. Epub 2007 Dec 6.

18.

Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.

Dobrzycka B, Mackowiak-Matejczyk B, Terlikowska KM, Kulesza-Bronczyk B, Kinalski M, Terlikowski SJ.

Eur Cytokine Netw. 2013 Jul-Sep;24(3):106-13. doi: 10.1684/ecn.2013.0340.

PMID:
24197277
19.

Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer.

Lambert-Messerlian GM, Steinhoff M, Zheng W, Canick JA, Gajewski WH, Seifer DB, Schneyer AL.

Gynecol Oncol. 1997 Jun;65(3):512-6.

PMID:
9190984
20.

[Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer].

Mu T, Li XP, Wang JL, Wang SJ, Wang Y, Sun XL, Cui H, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Aug;47(8):566-70. Chinese.

PMID:
23141174
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk